As of May 2026 Neurocrine Biosciences has a market cap of โน1.534 Trillion. This makes Neurocrine Biosciences the world's 1404th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On May 14th, 2026 the market cap of Neurocrine Biosciences was reported to be: